Perfusion Market Research Report - Forecast till 2027

Perfusion Market Information, By Type (Cardiopulmonary Bypass, Isolated Limb Perfusion, & Others), Application (Heart, Lung, & Others), Device Type (Normothermic Machine Perfusion, & Others), End User (Hospital, & Others) - Forecast Till 2027

ID: MRFR/Pharma/0386-HCR | February 2021 | Region: Global | 80 pages

Perfusion Market Scenario


Perfusion is a process of delivering oxygenated blood to all tissues. This technique is used in cardiac surgery where perfusion experts employ artificial blood pumps to thrust patients' blood through their body tissue by replacing the function of the heart while the cardiac surgeon operates. Perfusion can be used as chemotherapy technique for the treatment of melanoma occurring in arm or legs. With the help of this technique, flow of blood to and from the limb is stopped for a while by creating a band, and anticancer drugs are put directly in blood of the limb. This helps patients to receive a high dose of drugs in the area where the melanoma had occurred.    


Poor perfusion causes numerous severe health problems such as deep vein thrombosis and coronary artery disease. It has been observed that during major surgeries such as cardiothoracic surgeries and organ transplant, maintenance of perfusion is vital and to maintain this many preservation methods are being used. The two most important methods are machine perfusion (MP) and static cold storage (SCS). Although SCS is a highly adopted process for preservation, it is inefficient to maintain normal functioning of organs at high-risk. Hypothermic machine perfusion (HMP) has emerged as an effective solution to curb such problems. Every year more than one hundred thousand perfusion procedures are being performed around the globe.


Rising number of chronic diseases cases such as cardiac diseases, liver and kidney diseases often leads to organ transplant and is one of the major driver of the perfusion market. Moreover, rising cases of organ failure due to other factors such as improper diet, smoking and consumption of alcohol has led to the demand of effective perfusion systems. As per National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), more than 661,000 Americans have kidney failure which is a major driving force for the perfusion market. However, lack of awareness regarding perfusion systems in developing countries can limit the growth of this market.


The perfusion market is growing steadily and is expected to continue its growth during the forecast period. perfusion market is expected to grow at the CAGR of 4.1% during the forecast period and is estimated to reach around USD 1,527 million by 2023.


FIGURE 1   PERFUSION MARKET SHARE BY DEVICE TYPE, 2016 (%) Perfusion Market


Sources: National Kidney Foundation, Inc., National Center for Biotechnology Information, U.S. National Library of Medicine, National Institute of Diabetes and Digestive and Kidney Diseases (NIH), Directorate of Industries, Annual report, White paper, Company Presentation 


Market Assessment


Perfusion Market-


Sources: National Kidney Foundation, Inc., National Center for Biotechnology Information, U.S. National Library of Medicine, National Institute of Diabetes and Digestive and Kidney Diseases (NIH), Directorate of Industries, Annual report, White paper, Company Presentation


Segments

Perfusion market has been segmented on the basis of type which comprise of cardiopulmonary bypass, extracorporeal membrane oxygenation, isolated limb perfusion and others. Cardiopulmonary bypass is further sub-segmented into heart-lung machines, oxygenators, perfusion pumps, monitoring systems, cannulas, and other components.


On the basis of application, Perfusion market is segmented into lungs, heart, liver, kidneys and others. On the basis of device type, the market has been segmented into hypothermic machine perfusion, normothermic machine perfusion and others. On the basis of end user, it is segmented into hospital, specialty clinics, medical research centers, academic institutes, and others. 


Regional Analysis of Perfusion Market                


Considering the global scenario of the perfusion market, the Americas is the largest market of perfusion. The Americas mainly includes North America and Latin America. North America is a dominating region across the global market. Some major factors like technological advancement and growing number of organ transplants are major driving factors for the growth of the perfusion market. Europe is the second highest revenue generating region in the perfusion market. Europe is mainly divided into Eastern Europe and Western Europe. More developed countries of Western Europe like Germany, France and UK are holding major market share while the market in East European countries are also growing significantly. Due to the developing healthcare infrastructure, increasing healthcare expenditure, and growing adoption of new techniques for perfusion and organ preservations has led to the fastest growth of the Asia Pacific perfusion market. Middle East & Africa is expected to grow slow growth in this market. Middle Eastern countries like UAE and Saudi are dominating this market, it is mainly due to availability of top class medical facilities, high income and government support to improve public health.


Key Players of Perfusion Market

Some of the key players in perfusion market are Getinge AB (Sweden), Medtronic (Ireland), LivaNova PLC (U.K.), Terumo Medical Corporation (Japan), XENIOS AG (Germany), Lifeline Scientific, Inc. (U.S.), XVIVO Perfusion (Sweden), Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Harvard Bioscience, Inc. (U.S.), Ala Science (U.S.) and others.


Intended Audience



  • Perfusion system/device supplies companies

  • Perfusion system/device provides

  • Medical research laboratories

  • Research and development (R&D) companies

  • Market research and consulting service providers

  • Potential investors



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2023: USD 1,527 Million
  • 2027: Significant Value

    		•
      CAGR   4.1% (2017-2023)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Type, Device Type, Applications, End User
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Getinge AB (Sweden), Medtronic (Ireland), LivaNova PLC (U.K.), Terumo Medical Corporation (Japan), XENIOS AG (Germany), Lifeline Scientific, Inc. (U.S.), XVIVO Perfusion (Sweden), Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Harvard Bioscience, Inc. (U.S.), Ala Science (U.S.) and others
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers

  • Rising number of chronic diseases cases such as cardiac diseases, liver and kidney diseases often leads to organ transplant
  • Rising cases of organ failure

    		•


    Frequently Asked Questions (FAQ) :

    Perfusion is a Process of Delivering Oxygenated Blood to all parts of the Body. Perfusion is Widely Used During Cardiac Medical Procedures to Replace the Function of The Heart, Which Is Being Operated Upon.

    Perfusion Market Is Expected To Exhibit A Steady 4.1% Cagr Over The Forecast Period From 2017 To 2023.

    The Growing Prevalence of Cardiovascular Diseases Is The Major Driver For The Perfusion Market.

    North America is the Dominant Regional Market for Perfusion Technology And Devices.

    Leading Players in The Perfusion Market Include Xvivo Perfusion, Livanova Plc, And Medtronic, Among Others.

    BRIEF TOC

    1. Report Prologue

    2. Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    2.3 Market Structure

    2.4. Market Segmentation

    3. Research Methodology

    3.1 Research Process

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    3.5 Forecast Model

    4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Mega Trends

    4.5 Macroeconomic Indicators

    5. Market Factor analysis

    5.1 Value Chain Analysis

    5.2 Porter’s Five Forces

    5.3 Demand & Supply: Gap Analysis

    5.4 Pricing Analysis

    5.5 Investment Opportunity Analysis

    5.6 Merger and Acquisition Landscape

    5.7 Upcoming Trends

    5.7.1 Market Trends

    5.7.2 Technological Trends

    5.7.3 Insurance & Regulations

    5.7.4 Others

    6. Global Perfusion Market by Type

    6.1 Cardiopulmonary Bypass

    6.1.1 Heart-Lung Machines

    6.1.2 Oxygenators

    6.1.3 Perfusion pumps

    6.1.4 Monitoring systems

    6.1.5 Cannulas

    6.1.6 Other components

    6.2 Extracorporeal Membrane Oxygenation

    6.3 Isolated Limb Perfusion

    6.4 Others

    7. Global Perfusion Market by Application

    7.1 Lungs

    7.2 Heart

    7.3 Liver

    7.4 Kidney

    7.5 Others

    8. Global Perfusion Market by Device Type

    8.1 Hypothermic Machine Perfusion

    8.2 Normothermic Machine Perfusion

    8.3 Others

    9. Global Perfusion Market by End User

    9.1 Hospital and clinics

    9.2 Specialty Clinics

    9.3 Medical Research Centers and Academic Institutes

    9.4 Others

    10. Global Perfusion Market by Region

    10.1 Introduction

    10.2 Americas

    10.2.1 North America

    10.2.1.1 The US

    10.2.1.2 Canada

    10.2.2 Latin America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 Italy

    10.3.1.4 Spain

    10.3.1.5 UK

    10.3.1.6 Rest of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia

    10.4.1 China

    10.4.2 India

    10.4.3 Japan

    10.4.4 South Korea

    10.4.5 Rest of Asia

    10.5 Pacific

    10.6 Middle East and Africa

    10.6.1 UAE

    10.6.2 Saudi Arabia

    10.6.3 Egypt

    10.6.4 Rest of Middle East and Africa

    11. Competitive Landscape

    12. Company Profile

    13. Conclusion

    13.1 Key findings

    13.1.1 From CEO’s viewpoint

    13.1.2 Unmet needs of the market

    13.2 Key companies to watch

    13.3 Prediction of Perfusion Market

    14. Appendix

    LIST OF TABLES

    Table 1 Perfusion Industry Synopsis, 2020-2027

    Table 2 Global Perfusion Market Estimates and Forecast, 2020-2027, (USD Million)

    Table 3 Global Perfusion Market by Region, 2020-2027, (USD Million)

    Table 4 Global Perfusion Market by Type, 2020-2027, (USD Million)

    Table 5 Global Perfusion Market by Application, 2020-2027, (USD Million)

    Table 6 Global Perfusion Market by Device Type, 2020-2027, (USD Million)

    Table 7 Global Perfusion Market by End Users, 2020-2027, (USD Million)

    Table 8 Americas Perfusion Market by Type, 2020-2027, (USD Million)

    Table 9 Americas Perfusion Market by Application, 2020-2027, (USD Million)

    Table 10 Americas Perfusion Market by Device Type, 2020-2027, (USD Million)

    Table 11 Americas Perfusion Market by End Users, 2020-2027, (USD Million)

    Table 12 North America Perfusion Market by Type, 2020-2027, (USD Million)

    Table 13 North America Perfusion Market by Application, 2020-2027, (USD Million)

    Table 14 North America Perfusion Market by Device Type, 2020-2027, (USD Million)

    Table 15 North America Perfusion Market by End Users, 2020-2027, (USD Million)

    Table 16 U.S. Market by Type, 2020-2027, (USD Million)

    Table 17 U.S. Perfusion Market by Application, 2020-2027, (USD Million)

    Table 18 U.S. Market by Device Type, 2020-2027, (USD Million)

    Table 19 U.S Perfusion Market by End Users, 2020-2027, (USD Million)

    Table 20 Canada Market by Type, 2020-2027, (USD Million)

    Table 21 Canada Perfusion Market by Application, 2020-2027, (USD Million)

    Table 22 Canada Market by Device Type, 2020-2027, (USD Million)

    Table 23 Canada Perfusion Market by End Users, 2020-2027, (USD Million)

    Table 24 South America Market by Type, 2020-2027, (USD Million)

    Table 25 South America Perfusion Market by Application, 2020-2027, (USD Million)

    Table 26 South America Market by Device Type, 2020-2027, (USD Million)

    Table 27 South America Perfusion Market by End Users, 2020-2027, (USD Million)

    Table 28 Europe Market by Type, 2020-2027, (USD Million)

    Table 29 Europe Perfusion Market by Application, 2020-2027, (USD Million)

    Table 30 Europe Market by Device Type, 2020-2027, (USD Million)

    Table 31 Europe Perfusion Market by End Users, 2020-2027, (USD Million)

    Table 32 Western Europe Market by Type, 2020-2027, (USD Million)

    Table 33 Western Europe Perfusion Market by Application, 2020-2027, (USD Million)

    Table 34 Western Europe Market by Device Type, 2020-2027, (USD Million)

    Table 35 Western Europe Perfusion Market by End Users, 2020-2027, (USD Million)

    Table 36 Eastern Europe Market by Type, 2020-2027, (USD Million)

    Table 37 Eastern Europe Perfusion Market by Application, 2020-2027, (USD Million)

    Table 38 Eastern Europe Market by Device Type, 2020-2027, (USD Million)

    Table 39 Eastern Europe Perfusion Market by End Users, 2020-2027, (USD Million)

    Table 40 Asia Pacific Market by Type, 2020-2027, (USD Million)

    Table 41 Asia Pacific Perfusion Market by Application, 2020-2027, (USD Million)

    Table 42 Asia Pacific Market by Device Type, 2020-2027, (USD Million)

    Table 43 Asia Pacific Perfusion Market by End Users, 2020-2027, (USD Million)

    Table 44 Middle East & Africa Market by Type, 2020-2027, (USD Million)

    Table 45 Middle East & Africa Perfusion Market by Application, 2020-2027, (USD Million)

    Table 46 Middle East & Africa Market by Device Type, 2020-2027, (USD Million)

    Table 47 Middle East & Africa Perfusion Market by End Users, 2020-2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Perfusion Market

    Figure 3 Segmentation Market Dynamics for Global Perfusion Market

    Figure 4 Global Perfusion market Share, by Type, 2020-2027 (USD Million)

    Figure 5 Global Perfusion market Share, by Application, 2020-2027 (USD Million)

    Figure 4 Global Perfusion market Share, by Device Type, 2020-2027 (USD Million)

    Figure 5 Global Perfusion Market Share, by End Users, 2020-2027 (USD Million)

    Figure 6 Global Perfusion Market Share, by Region, 2020 (%)

    Figure 7 America Perfusion Market Share, by Region, 2020 (%)

    Figure 8 North America Perfusion Market Share, by Country, 2020 (%)

    Figure 9 Europe Perfusion Market Share, by Country, 2020 (%)

    Figure 10 Asia Pacific Perfusion Market Share, by Country, 2020 (%)

    Figure 11 Middle East & Africa Perfusion Market Share, by Country, 2020 (%)

    Figure 12 Global Perfusion Market: Company Share Analysis, 2020 (%)

    Figure 13 Getinge AB: Key Financials

    Figure 14 Getinge AB: Segmental Revenue

    Figure 15 Getinge AB: Geographical Revenue

    Figure 16 Terumo Medical Corporation: Key Financials

    Figure 17 Terumo Medical Corporation: Segmental Revenue

    Figure 18 Terumo Medical Corporation: Geographical Revenue

    Figure 19 Merck KGaA: Key Financials

    Figure 20 Merck KGaA: Segmental Revenue

    Figure 21 Merck KGaA: Geographical Revenue

    Figure 22 XENIOS AG: Key Financials

    Figure 23 XENIOS AG: Segmental Revenue

    Figure 24 XENIOS AG: Geographical Revenue

    Figure 25 Lifeline Scientific Inc.: Key Financials

    Figure 26 Lifeline Scientific Inc.: Segmental Revenue

    Figure 27 Lifeline Scientific Inc.: Geographical Revenue